← back to search

Samuel Short

University of North Carolina Health Care · US
Area of research
Infectious Diseases · Nephrology
Research interest
Research interests include COVID-19 Clinical Research Studies, Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, and Chronic Kidney Disease and Diabetes.
h-index
16
citations
3,957
works
50
NIH funding
primary concept
Medicine
email

Recent publications

Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
Journal of Thrombosis and Haemostasis 2025cited by 6position: firstdoi
Endothelial Dysfunction Biomarkers and CKD Incidence in the REGARDS Cohort
Kidney International Reports 2024cited by 12position: firstdoi
Abstract P085: Plasma Pro-enkephalin A And Incident Cognitive Impairment In The Regards Cohort
Circulation 2022cited by 0position: firstdoi
Acute kidney injury in patients treated with immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2021cited by 222position: middledoi
Rationale and design of the Kidney Precision Medicine Project
Kidney International 2021cited by 186position: middledoi
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
Annals of Internal Medicine 2021cited by 140position: middledoi
Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019–Related Respiratory Failure*
Critical Care Medicine 2021cited by 120position: middledoi
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
JAMA Internal Medicine 2020cited by 1,040position: middledoi
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
JAMA Internal Medicine 2020cited by 553position: middledoi
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19
Journal of the American Society of Nephrology 2020cited by 315position: middledoi
Bleeding Complications After Percutaneous Native Kidney Biopsy: Results From the Boston Kidney Biopsy Cohort
Kidney International Reports 2020cited by 64position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Katherine Wilkinson · University of Vermont3 papers (2022–2025)Mary Cushman · Kidney Research UK3 papers (2022–2025)Virginia J. Howard · Laurentian University2 papers (2022–2025)Katharine L. Cheung · University of Vermont2 papers (2022–2024)Orlando M. Gutiérrez · University of Alabama at Birmingham1 papers (2024–2024)Erin Mathiesen Hald · University of Vermont1 papers (2025–2025)Amanda K. Leonberg‐Yoo · Hospital of the University of Pennsylvania1 papers (2021–2021)Isaac E. Stillman · Weill Cornell Medicine1 papers (2020–2020)Elsayed Z. Soliman · University of Colorado Denver1 papers (2025–2025)Sonali Bose · SleepMed1 papers (2021–2021)Shruti Gupta · Winship Cancer Institute1 papers (2021–2021)Deidra C. Crews · Johns Hopkins University1 papers (2024–2024) · 1 papers (2022–2022)Lili Chan · Icahn School of Medicine at Mount Sinai1 papers (2021–2021)Marguerite R. Irvin · University of Alabama at Birmingham1 papers (2024–2024)Samantha K. Brenner · Tufts University1 papers (2021–2021)Sushrut S. Waikar · Boston Medical Center1 papers (2020–2020)Steven G. Coca · Mount Sinai Medical Center1 papers (2021–2021) · 1 papers (2022–2022)D. Leann Long · Fujian University of Traditional Chinese Medicine1 papers (2024–2024)